|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
OLIPUDASE ALFA |
A16AB25 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
PRALSETINIB |
L01EX23 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SOMATROGON |
H01AC08 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
TEZEPELUMAB |
R03DX11 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
VARIOUS |
R02AA20 |
RO
|
Not subject to prescription
|
13-07-2022 |
|
|
VALID
|
|
CIPROFLOXACIN |
J01MA02 |
RO
|
List I
|
12-07-2022 |
6260 |
|
VALID
|
|
LITHIUM |
N05AN01 |
RO
|
List I
|
12-07-2022 |
|
|
VALID
|
|
MOXIFLOXACIN |
J01MA14 |
RO
|
List I
|
12-07-2022 |
2487 |
27-02-2002 |
VALID
|
|
NALIDIXIC ACID |
J01MB02 |
RO
|
Not authorised
|
12-07-2022 |
|
|
VALID
|
|
NORFLOXACIN |
J01MA06 |
RO
|
List I
|
12-07-2022 |
3039 |
15-01-2003 |
VALID
|
|
OFLOXACIN |
J01MA01 |
RO
|
List I
|
12-07-2022 |
3900 |
31-10-2003 |
VALID
|
|
PEFLOXACIN |
J01MA03 |
RO
|
List I
|
12-07-2022 |
6953 |
15-04-1998 |
VALID
|
|
THIAMAZOLE |
H03BB02 |
RO
|
List II
|
12-07-2022 |
3642 |
23-07-2003 |
VALID
|
|
LOMEFLOXACIN |
S01AE04 |
RO
|
Not authorised
|
11-07-2022 |
|
|
VALID
|
|
FERROUS GLUCONATE |
B03AA03 |
RO
|
List II
|
24-06-2022 |
6754 |
02-06-1998 |
VALID
|
|
FERROUS GLYCINE SULFATE |
B03AA01 |
RO
|
Not authorised
|
23-06-2022 |
|
|
VALID
|
|
ACALABRUTINIB |
L01EL02 |
RO
|
List I
|
26-04-2022 |
|
|
VALID
|
|
ALPELISIB |
L01EM03 |
RO
|
List I
|
25-04-2022 |
|
|
VALID
|
|
DAUNORUBICIN |
L01DB02 |
RO
|
Not authorised
|
25-04-2022 |
|
|
VALID
|
|
ISAVUCONAZOLE |
J02AC05 |
RO
|
List I
|
25-04-2022 |
EMEA/H/C/002734 |
15-10-2015 |
VALID
|
|
GLUCARPIDASE |
V03AF09 |
RO
|
List I
|
29-03-2022 |
|
|
VALID
|
|
OPICAPONE |
N04BX04 |
RO
|
List I
|
29-03-2022 |
|
|
VALID
|
|
PITOLISANT |
N07XX11 |
RO
|
List I
|
29-03-2022 |
|
|
VALID
|
|
SEMAGLUTIDE |
A10BJ06 |
RO
|
List I
|
29-03-2022 |
|
|
VALID
|
|
SITAGLIPTIN |
A10BH01 |
RO
|
List II
|
29-03-2022 |
|
|
VALID
|
|
DEXIBUPROFEN |
M01AE14 |
RO
|
List I
|
28-02-2022 |
|
|
VALID
|
|
DESLORATADINE |
R06AX27 |
RO
|
List II
|
02-02-2022 |
2805 |
30-08-2002 |
VALID
|
|
BUTAMIRATE |
R05DB13 |
RO
|
Not subject to prescription
|
25-01-2022 |
6232 |
02-03-1998 |
VALID
|
|
CLOBUTINOL |
R05DB03 |
RO
|
Not authorised
|
25-01-2022 |
|
|
VALID
|
|
OXELADIN |
R05DB09 |
RO
|
Not subject to prescription
|
25-01-2022 |
918 |
|
VALID
|
|
BEROTRALSTAT |
B06AC06 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
GEMTUZUMAB OZOGAMICIN |
L01FX02 |
RO
|
List I
|
06-12-2021 |
|
|
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
RO
|
List I
|
06-12-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
